Global Polio Vaccine Market Growth 2021-2026

  • receipt Report ID : 158000
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 132
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Polio Vaccine will have significant change from previous year. By the most conservative estimates of global Polio Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1322.4 million in 2019. Over the next five years the Polio Vaccine market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 1638.1 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Inactivated Polio Vaccine (IPV)

Oral Polio Vaccine (OPV)

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Public

Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Sanofi

GSK

Bibcol

Serum Institute

Tiantan Biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Polio Vaccine Consumption 2016-2026

2.1.2 Polio Vaccine Consumption CAGR by Region

2.2 Polio Vaccine Segment by Type

2.2.1 Inactivated Polio Vaccine (IPV)

2.2.2 Oral Polio Vaccine (OPV)

2.3 Polio Vaccine Sales by Type

2.3.1 Global Polio Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Polio Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Polio Vaccine Sale Price by Type (2016-2021)

2.4 Polio Vaccine Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Polio Vaccine Sales by Application

2.5.1 Global Polio Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Polio Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Polio Vaccine Sale Price by Application (2016-2021)

3 Global Polio Vaccine by Company

3.1 Global Polio Vaccine Sales Market Share by Company

3.1.1 Global Polio Vaccine Sales by Company (2019-2021)

3.1.2 Global Polio Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Polio Vaccine Revenue Market Share by Company

3.2.1 Global Polio Vaccine Revenue by Company (2019-2021)

3.2.2 Global Polio Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Polio Vaccine Sale Price by Company

3.4 Global Manufacturers Polio Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Polio Vaccine Product Location Distribution

3.4.2 Players Polio Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Polio Vaccine by Region

4.1 Global Polio Vaccine by Region

4.1.1 Global Polio Vaccine Sales by Region

4.1.2 Global Polio Vaccine Revenue by Region

4.2 Americas Polio Vaccine Sales Growth

4.3 APAC Polio Vaccine Sales Growth

4.4 Europe Polio Vaccine Sales Growth

4.5 Middle East & Africa Polio Vaccine Sales Growth

5 Americas

5.1 Americas Polio Vaccine Sales by Country

5.1.1 Americas Polio Vaccine Sales by Country (2016-2021)

5.1.2 Americas Polio Vaccine Revenue by Country (2016-2021)

5.2 Americas Polio Vaccine Sales by Type

5.3 Americas Polio Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Polio Vaccine Sales by Region

6.1.1 APAC Polio Vaccine Sales by Region (2016-2021)

6.1.2 APAC Polio Vaccine Revenue by Region (2016-2021)

6.2 APAC Polio Vaccine Sales by Type

6.3 APAC Polio Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Polio Vaccine by Country

7.1.1 Europe Polio Vaccine Sales by Country (2016-2021)

7.1.2 Europe Polio Vaccine Revenue by Country (2016-2021)

7.2 Europe Polio Vaccine Sales by Type

7.3 Europe Polio Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Polio Vaccine by Country

8.1.1 Middle East & Africa Polio Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Polio Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Polio Vaccine Sales by Type

8.3 Middle East & Africa Polio Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Polio Vaccine Distributors

10.3 Polio Vaccine Customer

11 Global Polio Vaccine Market Forecast

11.1 Global Polio Vaccine Forecast by Region

11.1.1 Global Polio Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Polio Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Polio Vaccine Forecast by Type

11.7 Global Polio Vaccine Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Sanofi Sanofi Company Information

12.1.2 Sanofi Polio Vaccine Product Offered

12.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sanofi Main Business Overview

12.1.5 Sanofi Latest Developments

12.2 GSK

12.2.1 GSK Company Information

12.2.2 GSK Polio Vaccine Product Offered

12.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 GSK Main Business Overview

12.2.5 GSK Latest Developments

12.3 Bibcol

12.3.1 Bibcol Company Information

12.3.2 Bibcol Polio Vaccine Product Offered

12.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Bibcol Main Business Overview

12.3.5 Bibcol Latest Developments

12.4 Serum Institute

12.4.1 Serum Institute Company Information

12.4.2 Serum Institute Polio Vaccine Product Offered

12.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Serum Institute Main Business Overview

12.4.5 Serum Institute Latest Developments

12.5 Tiantan Biological

12.5.1 Tiantan Biological Company Information

12.5.2 Tiantan Biological Polio Vaccine Product Offered

12.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Tiantan Biological Main Business Overview

12.5.5 Tiantan Biological Latest Developments

12.6 IMBCA

12.6.1 IMBCA Company Information

12.6.2 IMBCA Polio Vaccine Product Offered

12.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 IMBCA Main Business Overview

12.6.5 IMBCA Latest Developments

12.7 Panacea Biotec Ltd

12.7.1 Panacea Biotec Ltd Company Information

12.7.2 Panacea Biotec Ltd Polio Vaccine Product Offered

12.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Panacea Biotec Ltd Main Business Overview

12.7.5 Panacea Biotec Ltd Latest Developments

12.8 Bio-Med

12.8.1 Bio-Med Company Information

12.8.2 Bio-Med Polio Vaccine Product Offered

12.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Bio-Med Main Business Overview

12.8.5 Bio-Med Latest Developments

12.9 Halfkin Bio-Pharmaceuticals

12.9.1 Halfkin Bio-Pharmaceuticals Company Information

12.9.2 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offered

12.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview

12.9.5 Halfkin Bio-Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Polio Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Inactivated Polio Vaccine (IPV)

Table 3. Major Players of Oral Polio Vaccine (OPV)

Table 4. Global Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 5. Global Polio Vaccine Sales Market Share by Type (2016-2021)

Table 6. Global Polio Vaccine Revenue by Type (2016-2021) & ($ million)

Table 7. Global Polio Vaccine Revenue Market Share by Type (2016-2021)

Table 8. Global Polio Vaccine Sale Price by Type (2016-2021)

Table 9. Global Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 10. Global Polio Vaccine Sales Market Share by Application (2016-2021)

Table 11. Global Polio Vaccine Value by Application (2016-2021)

Table 12. Global Polio Vaccine Revenue Market Share by Application (2016-2021)

Table 13. Global Polio Vaccine Sale Price by Application (2016-2021)

Table 14. Global Polio Vaccine Sales by Company (2019-2021) & (M Doses)

Table 15. Global Polio Vaccine Sales Market Share by Company (2019-2021)

Table 16. Global Polio Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Polio Vaccine Revenue Market Share by Company (2019-2021)

Table 18. Global Polio Vaccine Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Polio Vaccine Producing Area Distribution and Sales Area

Table 20. Players Polio Vaccine Products Offered

Table 21. Polio Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Polio Vaccine Sales by Region (2016-2021) (M Doses)

Table 25. Global Polio Vaccine Sales Market Share by Region (2016-2021)

Table 26. Global Polio Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Polio Vaccine Revenue Market Share by Region (2016-2021)

Table 28. Americas Polio Vaccine Sales by Country (2016-2021) & (M Doses)

Table 29. Americas Polio Vaccine Sales Market Share by Country (2016-2021)

Table 30. Americas Polio Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Polio Vaccine Revenue Market Share by Country (2016-2021)

Table 32. Americas Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 33. Americas Polio Vaccine Sales Market Share by Type (2016-2021)

Table 34. Americas Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 35. Americas Polio Vaccine Sales Market Share by Application (2016-2021)

Table 36. APAC Polio Vaccine Sales by Region (2016-2021) & (M Doses)

Table 37. APAC Polio Vaccine Sales Market Share by Region (2016-2021)

Table 38. APAC Polio Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Polio Vaccine Revenue Market Share by Region (2016-2021)

Table 40. APAC Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 41. APAC Polio Vaccine Sales Market Share by Type (2016-2021)

Table 42. APAC Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 43. APAC Polio Vaccine Sales Market Share by Application (2016-2021)

Table 44. Europe Polio Vaccine Sales by Country (2016-2021) & (M Doses)

Table 45. Europe Polio Vaccine Sales Market Share by Country (2016-2021)

Table 46. Europe Polio Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Polio Vaccine Revenue Market Share by Country (2016-2021)

Table 48. Europe Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 49. Europe Polio Vaccine Sales Market Share by Type (2016-2021)

Table 50. Europe Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 51. Europe Polio Vaccine Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Polio Vaccine Sales by Country (2016-2021) & (M Doses)

Table 53. Middle East & Africa Polio Vaccine Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Polio Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Polio Vaccine Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Polio Vaccine Sales by Type (2016-2021) & (M Doses)

Table 57. Middle East & Africa Polio Vaccine Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Polio Vaccine Sales by Application (2016-2021) & (M Doses)

Table 59. Middle East & Africa Polio Vaccine Sales Market Share by Application (2016-2021)

Table 60. Global Polio Vaccine Sales Forecast by Type (2021-2026) & (M Doses)

Table 61. Global Polio Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 62. Global Polio Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 63. Global Polio Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 64. Global Polio Vaccine Sales Forecast by Application (2021-2026) & (M Doses)

Table 65. Global Polio Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 66. Global Polio Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 67. Global Polio Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 68. Sanofi Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 69. Sanofi Polio Vaccine Product Offered

Table 70. Sanofi Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 71. Sanofi Main Business

Table 72. Sanofi Latest Developments

Table 73. GSK Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 74. GSK Polio Vaccine Product Offered

Table 75. GSK Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 76. GSK Main Business

Table 77. GSK Latest Developments

Table 78. Bibcol Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 79. Bibcol Polio Vaccine Product Offered

Table 80. Bibcol Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 81. Bibcol Main Business

Table 82. Bibcol Latest Developments

Table 83. Serum Institute Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 84. Serum Institute Polio Vaccine Product Offered

Table 85. Serum Institute Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 86. Serum Institute Main Business

Table 87. Serum Institute Latest Developments

Table 88. Tiantan Biological Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 89. Tiantan Biological Polio Vaccine Product Offered

Table 90. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 91. Tiantan Biological Main Business

Table 92. Tiantan Biological Latest Developments

Table 93. IMBCA Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. IMBCA Polio Vaccine Product Offered

Table 95. IMBCA Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 96. IMBCA Main Business

Table 97. IMBCA Latest Developments

Table 98. Panacea Biotec Ltd Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. Panacea Biotec Ltd Polio Vaccine Product Offered

Table 100. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 101. Panacea Biotec Ltd Main Business

Table 102. Panacea Biotec Ltd Latest Developments

Table 103. Bio-Med Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. Bio-Med Polio Vaccine Product Offered

Table 105. Bio-Med Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 106. Bio-Med Main Business

Table 107. Bio-Med Latest Developments

Table 108. Halfkin Bio-Pharmaceuticals Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 109. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offered

Table 110. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)

Table 111. Halfkin Bio-Pharmaceuticals Main Business

Table 112. Halfkin Bio-Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Polio Vaccine

Figure 2. Polio Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Polio Vaccine Sales Growth Rate 2016-2026 (M Doses)

Figure 7. Global Polio Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Polio Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Inactivated Polio Vaccine (IPV)

Figure 10. Product Picture of Oral Polio Vaccine (OPV)

Figure 11. Global Polio Vaccine Sales Market Share by Type in 2020

Figure 12. Global Polio Vaccine Revenue Market Share by Type (2016-2021)

Figure 13. Polio Vaccine Consumed in Public

Figure 14. Global Polio Vaccine Market: Public (2016-2021) & (M Doses)

Figure 15. Polio Vaccine Consumed in Private

Figure 16. Global Polio Vaccine Market: Private (2016-2021) & (M Doses)

Figure 17. Global Polio Vaccine Sales Market Share by Application (2016-2021)

Figure 18. Global Polio Vaccine Revenue Market Share by Application in 2020

Figure 19. Global Polio Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Polio Vaccine Revenue Market Share by Company in 2020

Figure 21. Global Polio Vaccine Sales Market Share by Regions (2016-2021)

Figure 22. Global Polio Vaccine Revenue Market Share by Region in 2020

Figure 23. Americas Polio Vaccine Sales 2016-2021 (M Doses)

Figure 24. Americas Polio Vaccine Revenue 2016-2021 ($ Millions)

Figure 25. APAC Polio Vaccine Sales 2016-2021 (M Doses)

Figure 26. APAC Polio Vaccine Revenue 2016-2021 ($ Millions)

Figure 27. Europe Polio Vaccine Sales 2016-2021 (M Doses)

Figure 28. Europe Polio Vaccine Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Polio Vaccine Sales 2016-2021 (M Doses)

Figure 30. Middle East & Africa Polio Vaccine Revenue 2016-2021 ($ Millions)

Figure 31. Americas Polio Vaccine Sales Market Share by Country in 2020

Figure 32. Americas Polio Vaccine Revenue Market Share by Country in 2020

Figure 33. Americas Polio Vaccine Sales Market Share by Type in 2020

Figure 34. Americas Polio Vaccine Sales Market Share by Application in 2020

Figure 35. United States Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Polio Vaccine Sales Market Share by Region in 2020

Figure 40. APAC Polio Vaccine Revenue Market Share by Regions in 2020

Figure 41. APAC Polio Vaccine Sales Market Share by Type in 2020

Figure 42. APAC Polio Vaccine Sales Market Share by Application in 2020

Figure 43. China Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Polio Vaccine Sales Market Share by Country in 2020

Figure 50. Europe Polio Vaccine Revenue Market Share by Country in 2020

Figure 51. Europe Polio Vaccine Sales Market Share by Type in 2020

Figure 52. Europe Polio Vaccine Sales Market Share by Application in 2020

Figure 53. Germany Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Polio Vaccine Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Polio Vaccine Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Polio Vaccine Sales Market Share by Type in 2020

Figure 61. Middle East & Africa Polio Vaccine Sales Market Share by Application in 2020

Figure 62. Egypt Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Polio Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz